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Introduction
Psoriasis is a chronic inflammatory disease where kerati-
nocytes are stimulated to hyperplasia by immunocytes
organised in a Th17/Th1-type (T- helper cell) domi-
nated response [1,2]. In about 15% of the patients with
psoriasis, arthritis will develop [3,4]. There have been
studies which demonstrated antagonism between atopy
and mainly Th-1 driven inflammatory and autoimmune
diseases such as rheumatoid arthritis in which the pre-
sence of atopy confers a milder course of the disease [5].
Serum IgE levels have been investigated in psoriatic
patients in the past. Nevertheless, there is little account
for clinical correlation and no patients with psoriatic
arthritis have been included in these investigations.
Previous studies have found increased total levels of IgE
together with increased sensibilization for specific inha-
lation allergens and even increased prevalence of atopic
diseases [6-10].
Aim
The aim of this paper is to describe clinical and serolo-
gical atopic manifestations in patients with psoriatic
arthritis in more detail and compare this to patients
with cutaneous psoriasis and a control group.
Patients and methods
One hundred and fifty outpatients with psoriatic arthri-
tis (PSA), 150 patients with cutaneous psoriasis without
arthritis (PSO), and a control group (CO) consisting of
150 patients with varicosities of the legs where included.
Patients filled in a questionnaire on clinical atopic mani-
festations and blood was drawn for total IgE and specific
inhalant IgE (Phadia AB, Sweden) determination.
Results
The prevalence of patient reported asthma was 8%, 15%
and 20% in PSA, PSO and CO groups respectively. For
hay fever we found prevalences of 9%, 14% and 19%.
The percentages of patients currently using inhalators
were: 3%, 5% and 12%. These differences were only sig-
nificant for PSA vs. CO (chi square p<0,05).
The percentages of patients with total IgE level > 100
kU/L was significantly lower in the PSA group com-
pared to the PSO and CO group. (13% vs. 31% vs. 23%
p = 0.022).
Also the percentage of patients with increased level of
inhalant allergen specific IgE > 0,35 phadiaU/L was
lower in the PSA group (20% vs. 37% vs. 36% p = 0,006).
Conclusions
Patients with psoriatic arthritis have lower prevalences
of clinical manifestations of atopy as well as of its sero-
logical markers when compared to patients with cuta-
neous psoriasis or non-psoriatic patients.
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